New pages
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
- 11:36, 17 March 2020 CNS lymphoma - null regimens (hist) [3,370 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 10:11, 17 March 2020 Anaplastic glioma - null regimens (hist) [5,528 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 14:26, 16 March 2020 Acute promyelocytic leukemia - null regimens (hist) [6,495 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 13:47, 16 March 2020 Acute myeloid leukemia - null regimens (hist) [17,324 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 22:24, 15 March 2020 Pancreatic NET - null regimens (hist) [6,554 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 15:49, 15 March 2020 Osteosarcoma - null regimens (hist) [4,189 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 15:37, 15 March 2020 Neuroendocrine tumor - null regimens (hist) [3,897 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 14:04, 15 March 2020 Low-grade glioma - null regimens (hist) [2,423 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 13:49, 15 March 2020 Leiomyosarcoma - null regimens (hist) [2,700 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 13:29, 15 March 2020 Kaposi sarcoma - null regimens (hist) [1,695 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 13:07, 15 March 2020 Gallbladder cancer - null regimens (hist) [1,815 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 09:39, 15 March 2020 Cutaneous T-cell lymphoma - null regimens (hist) [1,908 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 09:34, 15 March 2020 Adrenocortical carcinoma - null regimens (hist) [1,899 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 07:39, 12 March 2020 Study Groups (hist) [9,524 bytes] Jwarner (talk | contribs) (Created page with "This page contains information on various current and historical study groups. Definitions of acronyms are also available at the glossary. Additional links and resources a...")
- 17:19, 8 March 2020 COVID-19 coronavirus and cancer (hist) [75,113 bytes] Jwarner (talk | contribs) (Created page with "The intent of this page is to gather cancer-specific information relevant to [https://en.wikipedia.org/wiki/Coronavirus_disease_2019 COVID-19], the disease caused by [https://...") originally created as "COVID-19 and cancer"
- 01:43, 8 March 2020 University of Michigan Hematology Oncology Fellowship (hist) [3,951 bytes] PeterYang (talk | contribs) (Created page with "'''<big>For information about other programs, please visit the Hematology Oncology Fellowship Programs Directory.</big>''' '''People affiliated with this program are cord...")
- 15:24, 7 March 2020 Presentations (hist) [1,958 bytes] PeterYang (talk | contribs) (Created page with "<!--'''Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer. If th...")
- 10:32, 7 March 2020 Rectal cancer - null regimens (hist) [10,536 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 00:20, 7 March 2020 Cholangiocarcinoma - null regimens (hist) [5,272 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 22:30, 6 March 2020 Prostate cancer - null regimens (hist) [13,171 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 20:37, 6 March 2020 Pancreatic cancer - null regimens (hist) [8,386 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 10:13, 6 March 2020 Glossary (hist) [12,331 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to define terms specific to HemOnc.org as well as other commonly used acronyms. =HemOnc.org-specific terms= =Cooperative groups= *'''CALGB:''' Ca...")
- 01:32, 6 March 2020 Gastric cancer - null regimens (hist) [26,824 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 23:34, 5 March 2020 Hepatocellular carcinoma - null regimens (hist) [22,495 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 11:57, 5 March 2020 Endometrial cancer - null regimens (hist) [5,488 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 16:33, 4 March 2020 Nasopharyngeal carcinoma - null regimens (hist) [10,196 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 12:09, 4 March 2020 Gastrointestinal stromal tumor - null regimens (hist) [8,616 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 23:50, 3 March 2020 Esophageal cancer - null regimens (hist) [27,916 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 14:04, 3 March 2020 Head and neck cancer - null regimens (hist) [9,977 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 17:13, 29 February 2020 Tucatinib (ARRY-380) (hist) [1,519 bytes] Jwarner (talk | contribs) (Created page with "==Mechanism of action== From the [https://www.annalsofoncology.org/article/S0923-7534(19)32228-8/fulltext NCI Drug Dictionary]: An orally bioavailable inhibitor of the human e...")
- 19:15, 24 February 2020 Acute myeloid leukemia, NPM1-mutated (hist) [3,218 bytes] Jwarner (talk | contribs) (Created page with "{| class="wikitable" style="text-align:center; width:50%;" ! colspan="2" align="center" style="color:white; font-size:125%; background-color:#de2d26" |'''Section editor''' |-...")
- 23:48, 17 February 2020 Mesothelioma - null regimens (hist) [7,254 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 23:25, 15 February 2020 Ovarian cancer - null regimens (hist) [26,019 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 00:20, 14 February 2020 Renal cell carcinoma - null regimens (hist) [20,719 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 00:17, 13 February 2020 Small cell lung cancer - null regimens (hist) [8,989 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 21:07, 11 February 2020 Bladder cancer - null regimens (hist) [14,930 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 12:57, 11 February 2020 Cervical cancer - null regimens (hist) [3,452 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 12:16, 11 February 2020 Myelofibrosis - null regimens (hist) [6,553 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 00:12, 11 February 2020 Multiple myeloma - null regimens (hist) [19,249 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 16:39, 7 February 2020 Melanoma - null regimens (hist) [33,746 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 00:43, 7 February 2020 Colon cancer - null regimens (hist) [51,225 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 16:50, 5 February 2020 Non-small cell lung cancer - null regimens (hist) [59,346 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 22:56, 3 February 2020 Breast cancer - null regimens (hist) [42,664 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 22:32, 3 February 2020 Mantle cell lymphoma - null regimens (hist) [6,421 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 21:29, 3 February 2020 Diffuse large B-cell lymphoma - null regimens (hist) [17,419 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 15:44, 3 February 2020 Leiomyosarcoma (hist) [24,930 bytes] Jwarner (talk | contribs) (Created page with "{| class="wikitable" style="text-align:center; width:50%;" !colspan="2" align="center" style="color:white; font-size:125%; background-color:#08519c"|'''Section editor''' |- |s...")
- 15:20, 3 February 2020 Liposarcoma (hist) [14,044 bytes] Jwarner (talk | contribs) (Created page with "{| class="wikitable" style="text-align:center; width:50%;" !colspan="2" align="center" style="color:white; font-size:125%; background-color:#08519c"|'''Section editor''' |- |s...")
- 20:02, 1 February 2020 CAR T-cell toxicity management (hist) [1,390 bytes] PeterYang (talk | contribs) (outline)
- 14:52, 1 February 2020 Hodgkin lymphoma - null regimens (hist) [12,907 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 23:19, 30 January 2020 Osocimab (BAY 1213790) (hist) [661 bytes] Jwarner (talk | contribs) (Created page with "==Mechanism of action== Anti-Factor XIa antibody ==Preliminary data== ===Venous thromboembolism=== # '''FOXTROT:''' Weitz JI, Bauersachs R, Becker B, Berkowitz SD, Freita...")
